Beijing VDJBio Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Beijing VDJBio Co., Ltd. - overview
Established
2011
Location
Beijing, -, China
Primary Industry
Biotechnology
About
Based in Beijing, China and established in 2011, Beijing VDJBio Co. , Ltd. is a biotechnology company that focuses on the research and development of innovative antibody drugs for autoimmune diseases. Ziqiang Li, the founder and CEO of the company, used to be the director of the Cell Biology Department of Novo Nordisk China R&D Center.
In June 2023, the company raised series C funding led by new investor BCT Capital. Other returning investor Lotus Lake Ventures, new investors Beijing Yiyuan Investment Management, Hangzhou Hongcheng Investment Management, Hangzhou Huadian Investment Management Co. , Ltd. , Liyuan Venture Capital, and an individual investor also participated in the round.
The company's main products include IL-6R antibody and CTLA-4-Ig, etc. CTLA-4-Ig fusion protein is used to inhibit T cell activation. Its products are used in the treatment of autoimmune diseases and inflammation, among other fields.
Current Investors
Zhongguancun Biological Garden, THG Ventures, CCB Private Equity Investment Management
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.vdjbio.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Beijing VDJBio Co., Ltd. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer & General Manager | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.